Stay updated on FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma
Sign up to get notified when there's something new on the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page.

Latest updates to the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page has removed significant details regarding a study on the efficacy and safety of Foster 100/6mg NEXThaler in asthmatic patients, including the study's purpose, design, and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference14%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check51 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check87 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check101 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma
Enter your email address, and we'll notify you when there's something new on the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page.